Skip to content

InsiderTradesSIGMA

RecommendationsTOP BasketNEW Fundamental health TerminalNEW

Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FR US DE CH GB CA IT ES NL BE NO FI DK AU AT IE KR IN JP HK+ 8 markets

Recommendations
Fundamental health
Terminal
Companies
Insiders
Performance
Backtest
Compare

Markets
Sectors
Top movers
Leaderboard
Clusters
Heatmap
Archive

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

Built bySimon Azoulay

All systems operational

Companies · Health Care · InsiderTrades Sigma · page 51

Sector3,940

Health Care

SyntheticMR AB (publ)

SyntheticMR AB (publ)

Syros Pharmaceuticals, Inc.

T2 Biosystems, Inc.

TALEA GROUP SPA

TANDEM DIABETES CARE INC

TCR2 THERAPEUTICS INC.

TFF Pharmaceuticals, Inc.

TG Therapeutics, INC.

TRxADE HEALTH, INC

TScan Therapeutics, Inc.

TS인베스트먼트

TTK Healthcare Limited

Tabula Rasa HealthCare, Inc.

Tactile Systems Technology INC

Take Solutions Limited

Talaris Therapeutics, Inc.

Talea Group SPA

Talis Biomedical Corp

Talkspace, Inc.

Tandem Diabetes Care INC

Target Hospitality Corp.

Target Hospitality Corp.

Tarsus Pharmaceuticals, Inc.

Tatva Chintan Pharma Chem Limited

Tauriga Sciences, INC.

Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc.

Tchaikapharma High Quality Medicines AD

Tectonic Therapeutic, Inc.

Tekla Healthcare Opportunities Fund

Tekla Life Sciences Investors

Teladoc Health, Inc.

Telemedycyna Polska S.A.

Telix Pharmaceuticals Limited

Telix Pharmaceuticals Ltd

← PreviousPage 51 of 79Next →